Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
This modification allows for a longer drug half-life, raising compliance as it enables once-weekly dosing
(Source 12) 7
10.1016/s1474-4422(03)00305-3 Lancet Neurol
Promias success is directly based on two Phase II SBIR awards with Navy in 2000 and 2004, totaling $1.5 million in Phase II funding, along with additional CRP funding focused on transition
Not necessarily, but obesity is chronic for many patients
US$ 24.51
US$ 22.22
US$ 26.89
US$ 24.13
US$ 27.48
US$ 25.44
US$ 20.68
US$ 28.85
